Christopher Whidbey

Christopher Whidbey

Auto-generated profile, based on publicly available information

Christopher Whidbey

Department of Chemistry, Seattle University, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CWChristopher Whidbey
Christopher Whidbey
MHMaria Isabel Harrell
Maria Isabel Harrell
KBKellie Burnside
Kellie Burnside
LNLisa Ngo
Lisa Ngo
ABAlexis K. Becraft
Alexis K. Becraft
LRLakshmi Rajagopal
Lakshmi Rajagopal
Microbial infection of the amniotic fluid is a significant cause of fetal injury, preterm birth, and newborn infections. Group B Streptococcus (GBS) is an important human bacterial pathogen associated with preterm birth, fetal injury, and neonatal mortality. Although GBS has been isolated from amniotic fluid of women in preterm labor, mechanisms of in utero infection remain unknown. Previous studies indicated that GBS are unable to invade human amniotic epithelial cells (hAECs), which represent the last barrier to the amniotic cavity and fetus. We show that GBS invades hAECs and strains lacking the hemolysin repressor CovR/S accelerate amniotic barrier failure and penetrate chorioamniotic membranes in a hemolysin-dependent manner. Clinical GBS isolates obtained from women in preterm labor are hyperhemolytic and some are associated with covR/S mutations. We demonstrate for the first time that hemolytic and cytolytic activity of GBS is due to the ornithine rhamnolipid pigment and not due to a pore-forming protein toxin. Our studies emphasize the importance of the hemolytic GBS pigment in ascending infection and fetal injury.

6 July 2016 in mBio
Verified
Journal Article
Open access
PDF file
JVJay Vornhagen
Jay Vornhagen
PQPhoenicia Quach
Phoenicia Quach
EBErica Boldenow
Erica Boldenow
SMSean Merillat
Sean Merillat
CWChristopher Whidbey
Christopher Whidbey
LRLakshmi Rajagopal
Lakshmi Rajagopal
Preterm birth increases the risk of adverse birth outcomes and is the leading cause of neonatal mortality. A significant cause of preterm birth is in utero infection with vaginal microorganisms. These vaginal microorganisms are often recovered from the amniotic fluid of preterm birth cases. A vaginal microorganism frequently associated with preterm birth is group B streptococcus (GBS), or Streptococcus agalactiae . However, the molecular mechanisms underlying GBS ascension are poorly understood. Here, we describe the role of the GBS hyaluronidase in ascending infection and preterm birth. We show that clinical GBS strains associated with preterm labor or neonatal infections have increased hyaluronidase activity compared to commensal strains obtained from rectovaginal swabs of healthy women. Using a murine model of ascending infection, we show that hyaluronidase activity was associated with increased ascending GBS infection, preterm birth, and fetal demise. Interestingly, hyaluronidase activity reduced uterine inflammation but did not impact placental or fetal inflammation. Our study shows that hyaluronidase activity enables GBS to subvert uterine immune responses, leading to increased rates of ascending infection and preterm birth. These findings have important implications for the development of therapies to prevent in utero infection and preterm birth. IMPORTANCE GBS are a family of bacteria that frequently colonize the vagina of pregnant women. In some cases, GBS ascend from the vagina into the uterine space, leading to fetal injury and preterm birth. Unfortunately, little is known about the mechanisms underlying ascending GBS infection. In this study, we show that a GBS virulence factor, HylB, shows higher activity in strains isolated from cases of preterm birth than those isolates from rectovaginal swabs of healthy women. We discovered that GBS rely on HylB to avoid immune detection in uterine tissue, but not placental tissue, which leads to increased rates of fetal injury and preterm birth. These studies provide novel insight into the underlying mechanisms of ascending infection.

21 October 2016 in Science Immunology
Verified
Journal Article
Closed access
EBErica Boldenow
Erica Boldenow
CGClaire Gendrin
Claire Gendrin
LNLisa Ngo
Lisa Ngo
CBCraig Bierle
Craig Bierle
JVJay Vornhagen
Jay Vornhagen
KWKristina Adams Waldorf
Kristina Adams Waldorf
Group B streptococci overcome neutrophils in placental membranes, inducing fetal injury and preterm labor.

6 March 2015 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
CWChristopher Whidbey
Christopher Whidbey
JVJay Vornhagen
Jay Vornhagen
CGClaire Gendrin
Claire Gendrin
EBErica Boldenow
Erica Boldenow
JSJenny Mae Samson
Jenny Mae Samson
LRLakshmi Rajagopal
Lakshmi Rajagopal
Group B streptococci (GBS) are Gram‐positive bacteria that cause infections in utero and in newborns. We recently showed that the GBS pigment is hemolytic and increased pigment production promotes bacterial penetration of human placenta. However, mechanisms utilized by the hemolytic pigment to induce host cell lysis and the consequence on fetal injury are not known. Here, we show that the GBS pigment induces membrane permeability in artificial lipid bilayers and host cells. Membrane defects induced by the GBS pigment trigger K + efflux leading to osmotic lysis of red blood cells or pyroptosis in human macrophages. Macrophages lacking the NLRP3 inflammasome recovered from pigment‐induced cell damage. In a murine model of in utero infection, hyperpigmented GBS strains induced fetal injury in both an NLRP3 inflammasome‐dependent and NLRP3 inflammasome‐independent manner. These results demonstrate that the dual mechanism of action of the bacterial pigment/lipid toxin leading to hemolysis or pyroptosis exacerbates fetal injury and suggest that preventing both activities of the hemolytic lipid is likely critical to reduce GBS fetal injury and preterm birth.

10 August 2023 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
DJDominick J. Jenkins
Dominick J. Jenkins
BWBenjamin M. Woolston
Benjamin M. Woolston
MHM. Indriati Hood-Pishchany
M. Indriati Hood-Pishchany
PPPaula Pelayo
Paula Pelayo
AKAlyssa N. Konopaski
Alyssa N. Konopaski
EBEmily P. Balskus
Emily P. Balskus
The human vaginal microbiota is frequently dominated by lactobacilli and transition to a more diverse community of anaerobic microbes is associated with health risks. Glycogen released by lysed epithelial cells is believed to be an important nutrient source in the vagina. However, the mechanism by which vaginal bacteria metabolize glycogen is unclear, with evidence implicating both bacterial and human enzymes. Here we biochemically characterize six glycogen-degrading enzymes (GDEs), all of which are pullanases (PulA homologues), from vaginal bacteria that support the growth of amylase-deficient Lactobacillus crispatus on glycogen. We reveal variations in their pH tolerance, substrate preferences, breakdown products and susceptibility to inhibition. Analysis of vaginal microbiome datasets shows that these enzymes are expressed in all community state types. Finally, we confirm the presence and activity of bacterial and human GDEs in cervicovaginal fluid. This work establishes that bacterial GDEs can participate in the breakdown of glycogen, providing insight into metabolism that may shape the vaginal microbiota.

9 April 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JVJay Vornhagen
Jay Vornhagen
BABlair Armistead
Blair Armistead
VSVerónica Santana-Ufret
Verónica Santana-Ufret
CGClaire Gendrin
Claire Gendrin
SMSean Merillat
Sean Merillat
LRLakshmi Rajagopal
Lakshmi Rajagopal
Thirteen percent of pregnancies result in preterm birth or stillbirth, accounting for fifteen million preterm births and three and a half million deaths annually. A significant cause of these adverse pregnancy outcomes is in utero infection by vaginal microorganisms. To establish an in utero infection, vaginal microbes enter the uterus by ascending infection; however, the mechanisms by which this occurs are unknown. Using both in vitro and murine models of vaginal colonization and ascending infection, we demonstrate how a vaginal microbe, group B streptococcus (GBS), which is frequently associated with adverse pregnancy outcomes, uses vaginal exfoliation for ascending infection. GBS induces vaginal epithelial exfoliation by activation of integrin and β-catenin signaling. However, exfoliation did not diminish GBS vaginal colonization as reported for other vaginal microbes. Rather, vaginal exfoliation increased bacterial dissemination and ascending GBS infection, and abrogation of exfoliation reduced ascending infection and improved pregnancy outcomes. Thus, for some vaginal bacteria, exfoliation promotes ascending infection rather than preventing colonization. Our study provides insight into mechanisms of ascending infection by vaginal microbes.